KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Health Investors (NHI) Cash from Financing Activities (2016 - 2025)

National Health Investors (NHI) has disclosed Cash from Financing Activities for 17 consecutive years, with $57.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Financing Activities fell 49.01% year-over-year to $57.3 million, compared with a TTM value of $25.7 million through Dec 2025, up 289.48%, and an annual FY2025 reading of $25.7 million, up 289.48% over the prior year.
  • Cash from Financing Activities was $57.3 million for Q4 2025 at National Health Investors, up from -$41.9 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $139.8 million in Q1 2025 and bottomed at -$244.9 million in Q2 2022.
  • Average Cash from Financing Activities over 5 years is -$48.1 million, with a median of -$42.9 million recorded in 2024.
  • The sharpest move saw Cash from Financing Activities plummeted 571.7% in 2023, then soared 489.08% in 2025.
  • Year by year, Cash from Financing Activities stood at -$86.0 million in 2021, then surged by 91.44% to -$7.4 million in 2022, then tumbled by 571.7% to -$49.4 million in 2023, then surged by 327.37% to $112.4 million in 2024, then plummeted by 49.01% to $57.3 million in 2025.
  • Business Quant data shows Cash from Financing Activities for NHI at $57.3 million in Q4 2025, -$41.9 million in Q3 2025, and -$129.5 million in Q2 2025.